MDM2 and meningioma: To suppress the negative feedback of p53 via MDM2 in the hope of boosting the growth-inhibitory activity of p53, we combined CEP-1347 with an MDM2 inhibitor and investigated the effects of the combination on meningioma and glioblastoma cells [43].